PriceTracker GLP-1
Loading the index…

Try

Find the cheapest for me
Loading the index…

Try

GLP-1 TV · Clinician

Do Ozempic or Mounjaro Cause Depression? (Obesity Doctor Explains)

Clinician4:39Nov 2025

Today’s cheapest GLP-1$39/mo at Wellmedr, sale price.Compare all GLP-1 prices Price read 22 Nov 2026 from the seller’s own page, ranked by price alone. That price is a compounded drug, and compounded drugs are not FDA-approved. Not from the video’s creator.

Our summary

The channel addresses the claim that GLP-1 medicines cause depression and suicidal thoughts. He says the concern partly comes from early reports of a possible signal in some studies, and that US and European agencies looked into it. He also explains that most weight loss medicines carry cautions in their package inserts, which he links to earlier drugs such as rimonabant that acted on cannabinoid receptors in the brain and were associated with more suicidal behavior in early studies.

Published by Dr. Spencer Nadolsky on YouTube

As published by the channel. Not medical advice, and not an endorsement.

What else the video covers

According to the video, research on GLP-1 receptor agonists has found that, if anything, there is a mood benefit, including for depression, and no signal for suicidal ideation. He adds that most of his patients report better mood. As a caveat, he says he found one patient in a database of tens of thousands who stopped treatment because of suicidal thoughts, which he says does not prove cause and effect, though he thinks mood monitoring is worthwhile.

The main focus is a different issue he calls plausible: anhedonia, a flat lack of emotion and motivation. He explains that these drugs strongly affect the brain's dopamine reward system, which can help with addictive behaviors but may be too much for some people. He says he sees this most at the 10 to 15 mg doses of Zepbound (tirzepatide), often noticing it when patients lose interest in exercise or hobbies. His approach is to lower the dose, often from 15 mg to 10 mg, which he says usually does not cause weight regain, and occasionally to add bupropion. He advises anyone with these symptoms to talk to their doctor, since thyroid problems or worsening depression could also be the cause.

Our summary of what is said, in our words. Doses, results and prices are the speaker’s, not advice.

Takeaways

The main points, in the order they come up. Tap a time to play from there.

  1. 0:00 The speaker says the fear that GLP-1 medicines cause suicidal thoughts and depression is overstated and partly traces back to early study signals and package insert cautions.
  2. 0:31 He explains that package insert warnings on weight loss drugs stem partly from rimonabant, an older drug that acted on cannabinoid receptors.
  3. 1:02 According to the video, GLP-1 research shows a possible mood benefit and no signal for suicidal ideation, though he saw one patient in a database stop for suicidal thoughts and says this does not prove causality.
  4. 2:04 He says strong dopamine effects may cause anhedonia in some people, mostly at the 10 to 15 mg doses of Zepbound or tirzepatide, with loss of interest in exercise as a warning sign.
  5. 3:04 His approach is to lower the dose, often from 15 mg to 10 mg, and sometimes add bupropion, which he says restores motivation for many patients.
  6. 3:35 He advises patients with these symptoms to talk to their doctor, since hypothyroidism or worsening depression could be the cause instead.

Key moments

Tap one to play from there.

  1. 0:00 Do GLP-1s Cause Depression?
  2. 0:14 Why Early Studies Raised Concerns
  3. 0:46 What FDA and EU Investigations Found
  4. 1:17 How GLP-1s Affect Mood and Reward Pathways
  5. 1:51 The “Zepbound Blahs” and Anhedonia Explained
  6. 2:36 Signs Your Dose Might Be Too High
  7. 3:16 When Lowering the Dose Improves Mood
  8. 3:35 Using Bupropion to Restore Motivation

What the video says

As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.

Medication
Ozempic and Mounjaro

Questions this video answers

Do Ozempic or Mounjaro cause depression?

The speaker says he does not think these drugs cause depression. He states that research shows, if anything, a mood benefit, and that most of his patients report improved mood.

Do GLP-1 medicines cause suicidal thoughts?

According to the video, studies showed no signal for suicidal ideation, and he thinks it is safe to say the drugs do not cause it. He still recommends monitoring mood, and mentions one patient in a large database who stopped over suicidal thoughts, which he says does not prove cause and effect.

What is anhedonia on Zepbound or tirzepatide?

The speaker describes anhedonia as a flat lack of emotion and motivation rather than classic depression. He says he sees it anecdotally at the 10 to 15 mg doses, often when patients lose interest in exercise or hobbies.

What can be done if tirzepatide makes you feel flat or unmotivated?

He says he usually lowers the dose, often from 15 mg to 10 mg, which in his experience typically does not cause weight regain. If that does not work, he sometimes adds bupropion, and he advises patients to talk to their doctor to rule out other causes such as hypothyroidism.

Videos on the same question

The closest videos in the library by what is said in them, not by title.

Read next

Our guides closest to what this video covers, with prices checked weekly.

  • GLP-1s for binge eating: what semaglutide, liraglutide and tirzepatide trials show

    No GLP-1 is FDA approved for binge eating disorder; the only approved drug is lisdexamfetamine (Vyvanse). A 2026 meta-analysis of 25 randomized trials reports moderate drops in binge eating on GLP-1s, larger in people diagnosed with the disorder, but rates every trial at high risk or some concerns of bias. The one placebo-controlled liraglutide trial in diagnosed BED showed no significant difference. A tirzepatide versus Vyvanse trial is recruiting.

  • Mounjaro side effects: the label's numbers by dose, the low blood sugar risk, and how tirzepatide compares at weight-loss doses

    On Mounjaro's own label, the common side effects are stomach ones and they rise with the dose: nausea in 12, 15 and 18 percent of people at 5, 10 and 15 mg against 4 percent on placebo, diarrhea 12 to 17 against 9, and any gastrointestinal reaction in 37 to 44 percent against 20. Most of it happens while the dose is being raised and fades. Low blood sugar is rare on Mounjaro alone and is mainly a risk when it is added to insulin or a sulfonylurea. Below: the full table, the rare warnings, and why Zepbound's numbers for the same molecule look higher.

  • Mounjaro vs Ozempic, and the trial everyone quotes about it

    Mounjaro is tirzepatide and Ozempic is semaglutide: different molecules, not two brands of the same drug. Both are approved for type 2 diabetes, and the weight-loss versions are Zepbound and Wegovy. In the one head-to-head trial, SURMOUNT-5, tirzepatide produced 20.2% mean body-weight loss at 72 weeks against semaglutide's 13.7%. The detail almost every page omits: that trial dosed semaglutide to 2.4 mg in people without diabetes, which is the Wegovy range. Ozempic tops out at 2 mg. The famous result did not test Ozempic's dose range.

Next steps

Ozempic prices

Insurance

Find more like it

Dose changeMood and mental healthExercise and strengthAlcoholStopping and maintenanceHow it worksThe trials

Up next

More from this collection

Watched it? See what it costs.

Every GLP-1 program we track, ranked by what actually leaves your account.

Back to GLP-1 TV